• 1
    Beauchamp TL, Childress JF. Principles of biomedical ethics, 5th ed. New York: Oxford University Press; 2001.
  • 2
    Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, et al. Perceptions of cancer patients and their physicians involved in Phase I trials. J Clin Oncol 1995; 13: 106272.
  • 3
    Rodenhuis S, Van Den Heuvel WJA, Annyas AA, Koops HS, Sleijfer DTH, Mulder NH. Patient motivation and informed consent in a Phase I study of an anticancer agent. Eur J Cancer Clin Oncol 1984; 20: 45762.
  • 4
    Riecken HW, Ravich R. Informed consent to biomedical research in Veterans Administration hospitals. JAMA 1982; 248: 3448.
  • 5
    Ockene IS, Miner J, Shannon TA, Gore JM, Weiner BH, Ball SP. The consent process in the thrombolysis in myocardial infarction (TIMI—Phase I) trial. Clin Res 1991; 39: 137.
  • 6
    DeLuca SA, Korcuska LA, Oberstar BH, Rosenthal ML, Welsh PA, Topol EJ. Are we promoting true informed consent in cardiovascular clinical trials? J Cardiovasc Nurs 1995; 9: 5461.
  • 7
    Lynoe N, Sandlund M, Dahlqvist G, Jacobsson L. Informed consent: study of quality of information given to participants in a clinical trial. BMJ 1991; 303: 6103.
  • 8
    Searight HR, Miller C. Remembering and interpreting informed consent: a qualitative study of drug trial participants. J Am Board Fam Pract 1996; 9: 1422.
  • 9
    Ross M, Jeffords K, Gold J. Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study. AIDS Care 1993; 6: 7782.
  • 10
    White DR, Muss HB, Michielutte R, Cooper MR, Jackson DV, Fichards F, et al. Informed consent: patient information forms in chemotherapy trials. Am J Clin Oncol 1984; 7: 18390.
  • 11
    Estey A, Wilkin G, Dossetor J. Are research subjects able to retain the information they are given during the consent process. Health Law Rev 1994; 3: 3741.
  • 12
    Schaeffer MH, Krantz DS, Wichman A, Masur H, Vinicky JK. The impact of disease severity on the informed consent process in clinical research. Am J Med 1996; 100: 2618.
  • 13
    Bergler JH, Pennington AC, Metcalfe M, Freis ED. Informed consent: how much does the patient understand? Clin Pharmacol Ther 1980; 27: 43540.
  • 14
    Hassar M, Weintraub M. “Uninformed” consent and the wealthy volunteer: an analysis of patient volunteers in a clinical trial of a new anti-inflammatory drug. Clin Pharmacol Ther 1976; 20: 37986.
  • 15
    Hewlett S. Is consent to participate in research voluntary? Arthritis Care Res 1996; 9: 4004.
  • 16
    King NM. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics 2000; 28: 33243.
  • 17
    Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research. Int J Law Psychiatry 1982; 5: 31929.
  • 18
    St.Clair EW, Wilkinson WE, Pisetsky DS, Sexton DJ, Drew R, Kraus VB, et al. The effects of intravenous doxycycline therapy for rheumatoid arthritis. Arthritis Rheum 2000; 44: 10437.
  • 19
    The Human radiation experiments: final report of the President's Advisory Committee. New York: Oxford University Press; 1996.
  • 20
    Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987; 17: 204.
  • 21
    Miller C, Searight HR, Grable D, Schwartz R, Sowell C, Barbarash RA. Comprehension and recall of the informational content of the informed consent document: An evaluation of 168 patients in a controlled clinical trial. J Clin Res Drug Dev 1994; 8: 23748.
  • 22
    Lawson SL, Adamson HM. Informed consent readability: subject understanding of 15 common consent form phrases. IRB 1995; 17: 16-9.
  • 23
    Howard JM, DeMets D, the BHAT Research Group. How informed is informed consent? The BHAT experience. Control Clin Trials 1981; 2: 287303.